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ABSTRACT
Alteration in Serum Enzyme Levels, Activity of Hepatic
Monooxygenases, and Hepatocyte Morphology Due to
Liver Enzyme Inducers in Microtus montanus
by
Jeffrey Robert Hincks, Master of Science
Utah State University, 1983
Major Professor: Dr. William A. Brindley
Department: Biology
Microtus sp. have been used in microcosm simulations of polluted
environments.

In this study, female Microtus montanus (mountain vole),

8 - 12 weeks of age, were pretreated with phenobarbital (PB), B-naphthoflavone (BNF), or Aroclor 1254 (PCB) for 3 consecutive days.

Doses

ranged from 5 to 80 mg/kg for each pretreatment, while control animals
received saline or corn oil only.

The voles were sacrificed 1 day after

the last dose of PB and 2 days after BNF and PCB.

Hepatic microsomal

enzyme activity of aniline hydroxylase (AH), p-nitroanisole-0-demethylase (PNA) and cytochrome C reductase (CCR) were measured in relation to
dose and type of inducer pretreatment.

PB produced an induction for

all 3 enzyme systems at the higher doses.

Variation of PB dose from 5

to 80 mg/kg produced a biphasic effect in AH, PNA increased with each
higher dose, and CCR showed a triphasic effect.

BNF caused no signifi-

cant change in AH activity, a biphasic response in PNA, and a triphasic
effect in CCR with the highest activity at the 20 mg / kg dose.

PCB dem-

ix
onstrated slight induction at low doses but higher doses produced no
change or a decrease in enzyme activity.
serum malathion carboxylesterase occurred.

No increase in SGPT levels or
Histological investigations

revealed 2 morphological phases related to the type of induction.

Low

level induction showed foamy, vacuolated hepatocytes, while high induction produced very large, hypertrophied hepatocytes.

A positive con-

trol for hepatic necrosis using 0.1 ml/kg carbon tetrachloride showed
significant increases in serum enzymes and severe centrilobular and midzonal acute hepatic necrosis.

Therefore, these results show a differ-

ence in induction potential of BNF and PCB compared to other rodents.
Also, this study indicates the importance of inducer dose on the effect
of hepatic monooxygenase activity.

( 91 pages)

INTRODUCTION
The hepatic monooxygenase system plays an important role in both
the detoxification as well as in the activation of numerous xenobiotics.
A considerable amount of work has been done on the inductive properties
of liver monooxygenases in laboratory inbred animals.
has been shown toward outbred or wild animals.

Little attention

Nebert and Gelboin

(1969), Walker (1978), and Kato (1979) all illustrate the high diversity
of species differences in hepatic monooxygenases activity and stress the
importance of studying various species of animals.
Investigations on monooxygenase activity were performed in endrinresistant and susceptible pine voles, Microtus pinetorum(Hartgrove

et

al., 1977) and in the grey-tailed vole, !:1_. canicandus (Brindley, 1979),
but little work has been published on the mountain vole,!:!_. montanus.
Results of Makary and Brindley (1983) show the patterns of microsomal
induction of bi phenyl hydroxylation of!:!_. montanus to be much different
than reported for rats or mice.
seen in hamsters.

The pattern resembles the induction

Wang (1981) studied the inducing effects of pheno-

barbital (PB), 3-methylcholanthrene (3-MC), and B-naphthoflavone (BNF)
on 2 strains of mice, B6 and 02,

The B6 mice showed microsomal en-

zyme induction to all 3 pretreatments, whereas the special strain of
D2 mice were induced by PB but not by 3MC or BNF.

Preliminary tests

showed !:1_. montanus to have hepatic microsomal enzyme induction similar
to that of the 02 strain of mice.
Voles have been used in microcosms for environmental chemical exposure studies (Cole

et al., 1976, and Gile and Gillett, 1977).

The

2

Environmental Protection Agency has also used Microtus sp. in microcosm
exposure studies and found these animals useful in modeling environmental accumulation of pollutants.

More knowledge can be obtained

from microcosm studies by a better understanding of the toxicology
and physiology of the vole.
Chemicals often used by hepatic induction are PB for "cytochrome
P-450type" induction and BNF for a "cytochrome P-448 type
Arocl or 1254 (PCB) shows both

11

types

11

11

induction.

of inducing properties as reported

by Alvares and Kappas (1977) and Ryan et al. (1979) .

These 3 enzyme

inducers develop a good insight to the inductive responses of hepatic
monooxygenases.

Studies incorporating the use of PB, BNF, and/or PCB

for enzyme induction investigation usually use only one or two different dose levels.

Little is known about the effects of varying the

inducer pretreatment levels on the hepatic monooxygenase activity.
It is not known if, at higher dos es, these inducers become increasingly
more toxic, resulting in a decrease in the inductive propert i es.
Assessment of liver damage is often determined by levels of 1 iver
enzymes in the serum.

Compared to other liver function tests, levels

of serum glutamic pyruvic transaminase (SGPT) appears to be a more
sensitive test in determining liver damage (Plaa, 1976).
Ketterman (1981) have shown that serum levels of malathion
esterase
reticulum.

Talcott and
carboxyl-

may fluctuate due to structural changes in liver endoplasmic
Monitoring serum enzyme levels as an indication of bio~

chemical changes in the liver during enzyme induction has not been
fully investigated.
The purpose of this study was based on four main objectives.
first was to further understand the hepatic monooxygenase system and

The

3

its induction potentials of Microtus montanus using the inducers PB,
BNF and Aroclor 1254.

Second, to compare the relation of dose and type

of inducer pretreatment to the level of microsomal enzyme activity.
The third objective was to quantify any change in SGPT and serum malathion carboxylesterase due to the dose and type of inducer administered
to M. montanus .

The last objective was to determine any histological

changes in the liver of the voles based on the dose and type of inducer.

4

LITERATURE REVIEW
Cytochrome P-450 Dependent Monooxygenase System
The cytochrome P-450 dependent monooxygenase system plays an important role in both the detoxification as well as the activation
numerous xenobiotics.

of

This enzyme system is found in bacteria, yeasts,

fish, birds, mammals and other life forms.

In mammalian systems, the

monooxygenases are incorporated in many tissues with the highest activity occurring in hepatic tissue.
Hepatic monooxygenases deto xify some xenobiotics by an hydro xylation of lipophilic compounds, allowing easier excretion of the metaboToxic compounds may be converted, by the hepatic oxidative

lites.

reaction, to a less potent metabolite resulting in a decrease in to xicity.

Lampe and Butschak (7978) discussed the role of cytochrome P-450

in the activation

of several xenobiotics.

This enzyme system may

cause the formation of reactive epoxides or hydroxylated products which
may eventually transform into electrophilic reactants.

These react-

ants can then produce cytoto xic, mutagenic, teratogenic or carcinogenic
effects depending on the dose and other pharmacokinetic parameters
involved.
Sato and Omura (7978), in their book, have presented the history
and current understanding of cytochrome P-450.

Recent reviews by

Walker (7978), Bresnick (7978), Kato (7979), Nebert (7979), Ullrich
(7979), Rees (7979), and Goldberg (7980), have looked at the induction
capabilities of the cytochrome P-450 monooxygenase system and the
occurrence of species differences.

5

Mechanism and organization of the hepatic
monooxygenase system
The hepatic monooxygenase system
reticulum of hepatocytes.

is located in the endoplasmic

These systems are isolated in vitro in

vesicles of endoplasmic reticulum called microsomes prepared by centrifuging the mitochondrial supernatant 105,000 x g for 1 hr (Goldstein

et al., 1974).

contains hemoproteins

The resultant pellet, the microsomal fraction,
incorporated within the membrane vesicles.

These hemoproteins are known as cytochrome P-450.

The name comes from

the absorption peak seen at 450 nm when the complex of the reduced form
of the hemoprotein is bound to carbon monoxide (Sato and Omura, 1978).
The monooxygenase system utilizes electron transfer complexes to
permit the hydroxylation of various substrates.

The substrate binds

with the oxidized form of cytochrome P-450 and is reduced by accepting
one electron from a flavoprotein called NADPH cytochrome P-450 reductase (Yang, 1977; Sato and Omura, 1978}, Figure l.

Molecular oxygen

is then bound to the reduced P-450-substrate complex.
is received by the complex forming an

11

A second electron

acti vated oxygen" allowing one

oxygen atom to be inserted into the substrate.

This second electron

can be supplied by either NADPH (by way of the flavoprotein) or NADH
using the transport systems of a flavoprotein and cytochrome b5 (Hildebrant and Estabrook, 1971). The other oxygen atom forms water, and the
oxidized substrate is released allowing the cytochrome P-450 to return
to the oxidized form.

The electron transfer system is shown in Figure

1.

The organization of the monooxygenase enzymes within the membrane
have been reviewed by Yang (1977).
ported results that support the

11

Franklin and Estabrook (1971) re-

rigid 11 system.

This model describes
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NADPH-cytochrome P-450 reductase as being surrounded by many cytochrome
P-450 molecules forming fixed clusters throughout the membrane.

Ac-

cording to the rigid system, when 50% of the reductase is inactivated,
only 50% of the cytochrome P-450 can be enzymatically reduced.

Frank-

lin and Estabrook (1971) showed this to occur using mersalyl to inactivate the reductase.
The "nonrigid" model was adopted by Yang (1977) showing that cytochrome P-450 and the reductase are not rigidly associated and that these
enzymes are free to move laterally in the membrane.

This was illustrat-

ed by inactivating up to 80% of the NADPH-cytochrome reductase with
mersalyl, yet, most all of the cytochrome P-450 was still reduced enzymatically, but at a slow rate.
The model described by Peterson

et al. (1976), incorporates both

the "rigid" and "nonrigid" models by looking at the temperature dependent kinetics of cytochrome P-450 reductase.

This model has the reduc-

tase, surrounded by several cytochrome P-450 molecules, partially protruding out of the membrane.

Also, a number of cytochrome P-450 mole-

cules are freely dispersed in the membrane and all the enzymes have free
lateral movement within the membrane.

It is reasonable to state that

the distribution of enzymes, in the microsomal membrane, is heterogenous and that they are mobile within the membrane.
be more support for the model adopted by Peterson

There tends to

et al. (1976) in

describing the organization of the microsoma1 monooxygenase system.
Induction capabilities and multiple
forms of cytochrome P-450
The term hepatic enzyme induction refers to the ability of a substrate to enhance the activity of that enzyme, and usually related en-

8

zymes, by promoting the synthesis

of the enyzmes.

Kupfer (1970) looked

at the variation in hexabarbital-induced sleep in rats.

Rats pretreated

with phenobarbital or DDT had a considerable decrease in their
hexabarbital-induced sleep compared to controls.

This is due to tht

induction capabilities of the pretreatment compounds on the hexabarbital metabolizing enzyme causing hexabarbital to become inactivated
and excreted more rapidly.
The preferred procedure to find the degree of induction of
hepatic enzymes is to prepare hepatic microsomal fractions and assay
the enzyme activity with suitable substrates (Conney, 1967).

Quite

often an aromatic hydroxylation, i.e. aniline hydroxylase and some
type of dealkylation, i.e • .E_-nitroanisole-Q_-demethylase, are both investigated to determine any variations that may occur in the enzyme
activity dependent on the substrate.

Recent studies by Katoh et al.

(1981) and Rikans and Notley (1982) utilize aniline and p-nitroanisole
as the substrates to monitor microsomal monooxygenase activity.

Cyto-

chrome C reductase activities are often measured to determine the change
in rate of electron flow to the cytochrome P-450-substrate complex,
giving an indication of induction.
Many factors can affect the promotion of enzyme induction.
berg (1980) mentions some of these important factors as:

Gold-

species var-

iability, induction dependency upon age as well as sex of the animal
and stage of sexual maturity.

Also, seasonal and nutritional factors

can have an effect on enzyme activity.

These fluctuations in activity

must be considered in studies involving enzyme induction.
Reviews by Bresnick (1978) and Rees (1979) detailed the mechanism
of induction at the molecular level.

The inducer causes stimulation of

9

nuclear RNA as well as a decrease rate of degradation of mRNA.

This

implies the inducers produce nuclear changes in the cells affecting increased synthesis of the needed enzymes and also decrease the rate of
degradation of these enzymes.

An inducer compound-receptor complex,

needed to start the chain of actions has not been isolated but believed
to exist (Rees, 1979; Nebert, 1979) .
In the review by Nebert and Jensen (1979), a gene locus-Ah, associated with AHH activity, also regulates the metabolism of several other
compounds.

Aniline hydroxylase and cytochrome C reductase are not as-

sociated with the Ah locus.

As a result, genetic control over enzyme

metabolism, due to inducers, is specific for some substrates and fairly
non-specific for many other substrates.

Conney (1967) states that there

are at least two types of inducers; phenobarbital type and
3-methylcholanthrene type. Many compounds are similar to phenobarbital
(PB) in stimulating metabolic pathways in liver microsomes including
oxidation and reduction reactions.

Whereas, polycylic aromatic hydro-

carbons, typified by 3-methylcholanthrene (3-MC) and B-naphthoflavone
(BNF), stimulate a more limited group of enzymes.

The PB type inducers

stimulate a Soret peak of the reduced cytochrome P-450-CO complex around
450 nm.

In contrast, the 3-MC type inducers stimulate a Soret peak of

the reduced cytochrome-CO complex closer to 44 8 nm.

The differences

between PB and 3-MC have helped in identification of different forms of
cytochrome P-450 in the hydroxylation enzyme systems in liver microsomes.
In the review by Nebert (1979), he discusses the possibility of
mammalian tissues containing hundreds of different inducible forms of
cytochrome P-450.

He compares the diversity of the metabolic capabili-

10
ties of microsomal monooxygenases to that of the immune system in response to antigens.

Yet, the actual

these systems is very specific.

mechanistic response in both of

Several studies have reported the iso-

lation of different forms of cytochrome P-450.

Comai and Gaylor (1973)

separated three forms of cytochrome P-450 from rat livers.

The differ-

ent forms were determined by spectral changes that occur when the P-450
complexes combined wtih various ligands.

Welton and Aust (1974) isolat-

ed these different forms of cytochrome P-450 in rats by
SDS-polyacrylamide gel electrophoresis.

Pretreatment with PB induced

the P-450 with a molecular weight 44,000, while 3-MC increased the
amount of P-450 with molecular weight 53,000.

The hemoprotein that

predominated in microsomes of untreated rats had a molecular weight of
50,000.

Haugen et

al. (1975) isolated a fourth type of P-450 with

the molecular weight of 60,000.

They also determined the different

types of cytochrome P-450 hydroxylated various substrates preferentially.
Recently, considerable work has been done on the inductive effects
of polychlorinated biphenyls (PCB).

Ryan et

al. (1977) and Alvares and

Kappas (1977) both presented results demonstrating that the PCB mixture
Aroclor 1254 has the inductive potential similar to that of PB and 3MC.

Yoshimura et al. (1978) investigated the inductive effect of

Kanechlor 400, a Japanese PCB mixture, and found the similar effect
seen with Aroclor 1254.

Poland and Glover (1977), Parkinson et al.

(1980) and McKinney and Singh (1981) have studied the structure-activity
relationship of various PCB congeners on the hepatic monooxygenases.
The specific congeners produced either; PB type,
or no

effect on the inductive properties.

3-MC type, both,

This explains why Aroclor
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1254, a mixture of various PCB congeners, produces effects similar to
both PB and 3-MC.

Ryan et al. (1979) isolated three specific forms of

hepatic cytochrome P-450; P-450a, P-450b, and P-450c from rats pretreated
with Aroclor 1254.

The P-450a and P-450b were also found in PB pre-

treated rats but in 3-MC pretreated rats, P-450a and P-450c were present.

The forms of cytochrome P-450 found in the PB and 3-MC treated

rats were indistinguishable from the corresponding forms from Aroclor
1254 treated rats based on spectral changes, enzyme activity and antisera
testing.
Species differences in hepatic
monooxygenase activity
Detailed reviews by Walker (1978) and Kato (1979) have covered
differences in hepatic monooxygenase activity of different species.
Both articles illustrate the wide range of enzyme activity that can
occur in the monooxygenase system.
zymes

This variation in detoxifying en-

illustrates the importance in understanding the relative toxicity

of compounds in different species.
Philpot and Bend (1975) investigated benzpyrene hydroxylase activity in 3-MC pretreated rabbit and rat hepatic microsomes.

Rabbits

showed a decrease in benzpyrene hydroxylase when pretreated with 3-MC
compared to the controls.

Rats showed a large induction of

hydroxylase when pretreated with 3-MC.
in study by Miranda and Chhabra (1980).

benzpyrene

Similar results are produced
All species tested produced an

increase in activity of aniline hydroxylase, ethylmorphine demethylase,
7-ethoxycoumarin

deethylase and AHH when pretreated with PB.

Pre-

treatment of 3-MC increased ~epatic aniline hydroxylase and AHH activities in rats, mice, and guinea pigs and 7-ethoxycoumarin deethylase

12

activity in mice and rats.

In contrast, these enzyme activities were

inhibited by 3-MC pretreatment in rabbits.
Makary and Brindley (1983)

investigated species differences in

biphenyl hydroxylation between the mountain vole and white mice.

The

vole produced increases in 2-, 3-, and 4-hydroxybiphenyl with pretreatment of PB, while the mice only increased in 3- and 4-hydroxybiphenyl.
With 3-MC or BNF pretreatment, the mice had a high increase in 2hydroxylation over 3- and 4-hyrlroxylation; whereas the vole showed
only slight increases in all 3 metabolites.
Hepatotoxicity
The liver is a multifunctional organ, but the main interest of this
study is the capability of hepatocytes to metabolize xenobiotics.

The

classical way of expressing the relation of the hepatocytes, to the
vascular supply and the biliary system is by the hexagonal liver lobule
(Rappaport, 1969). In the center of this lobule

is the central vein and

at each apex of the hexagonal shape is located a portal triad made up
of the portal vein, hepatic arterial~ and bile duct.

Using this con-

figuration, lesions of the liver parenchyma have been described as
centrilobular,

midzonal, or periportal .

Rappaport (1969) has described the functional unit of the liver as
the liver acini.

This region has the portal triad at the center

bordered by two or more central veins.

The arterial blood as well as

venous blood from the portal vein passes through the hepatic sinuses in
close contact with the hepatic cells.
Hepatocytes lining the sinusoids are thought to have varying degree of enzymatic activity based on the location in the liver lobule.
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Sweeney et al. (1978a, b) and Wanson et al. (1975) have investigated
hepatocyte heterogeneity.

Wanson, et al. (1975) isolated centrilobulars

from periportal cells and determined the centrilobular to be larger in
size and to contain more smooth endoplasmic reticulum.

Sweeney et al.

(197 8b) demonstrated that pretreatment with phenobarbital or
3-methylcholanthrene resulted in different sedimentation velocity patterns.

Baron et al. (1978),

using immunohistochemical methods, de-

termined that centrilobular hepatocytes contain larger concentrations
of cytochrome P-450.

Baron et al. (1978)

also showed that cytochrome

P-450 induced by 3MC or PB have different distributions in the liver
lobule.
The concept of heterogeneity plays an important role in discussing
liver damage due to chemical exposure.

Nakatsugawa et al. (1980) ex-

plains how the liver lobule may function as a "reverse-phase chromatograph" during the passage of xenobiotics through the liver.

The dif-

ferences of uptake and metabolism of to xic chemicals by hepatocytes
reflectthemorphological lesion.

James et al. (19 81) illustrates

this point well by using 3 different hepatotoxins that produced 3 different necrotic areas within the liver lobule.
periportal lesions due

Allyl alcohol produces

to the higher concentrations of alcohol dehy-

drogenase in this region.

Alcohol dehydrogenase converts allyl alcohol

into the toxic compound allyl aldehyde.

Bromobenzene and carbon tetra-

chloride are metabolized to toxic products by monooxygenases in the
centrilobular and midzonal regions.

The necrosis produced by bromo-

benzene is predominantly centrilobular whereas carbon tetrachloridenecrosis is midzonal and centrilobular.

This shows how the location of

the lesion is related to where the compound is metabolically activated.
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The liver lesion observed due to chemical exposure depends not
only on the chemical involved, but also the period of exposure.

Acute

exposure usually reveals lipid accumulation in the hepatocytes, cellular
necrosis, or hepatobilliary dysfunction (Plaa, 1980).

Chronic exposures

result in cirrhosis of the liver or neoplastic changes.
This study, presented in the following pages, deals with the possibility of hepatocyte degeneration and necrosis due to acute exposures
of various chemicals.

Degeneration refers to abnormal morphological

changes which may be seen by c~lular swelling, accumulation of fat within the cell, or the appearance of intracellular inclusions; also there
may be an abnormal accumulation of extracellular material (Thomson,
1978).

Necrosis refers to rapid tissue death or irreversibl~ degener-

ation.

Tissue may be sectioned, fixed and stained to observe any ab-

normal changes produced by an injurious chemical.
Another procedure to assess liver dysfunctions is to monitor
serum enzyme levels that vary due to hepatic lesions.

Serum glutamic

pyruvic transaminase (SGPT) activity tends to elevate in animals treated
with hepatotoxic compounds (Todd-Sanford, 1974).

SGPT appears to be

a more sensitive index of hepatic injury than some of the other serum
assays (Balazs et al., 1962; Traiger and Plaa, 1971; and Thomson,
1978).

Several recent studies measured SGPT levels to determine the

degree of hepatotoxicity occuring due to treatments of various chemicals (Freeman and Harbison, 1981; Ueno et al. 1980; and Suarez

et al.

1981).
Pessayre

et al. (1980) looked at SGPT activity and sections of

livers to determine the extent of hepatotoxicity.

They suggested that

microsomal enzyme inducers may have additive effects on the hepototoxic-
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ity of acetaminophen by increasing the formation of the reactive metabolite.

The increases in SGPT levels were well correlated with the

liver necrosis evident from histological examination.
High levels of certain serum enzymes may also have a beneficial
effect in metabolizing toxic compounds to a less reactive form.

Studies

by Seume and O'Brien (1960) and Main and Braid (1962) have shown that
the low toxicity of malathion in mammals is due to the hydrolysis of
malathion to the carboxylic acid derivatives by carboxylesterases located in the liver and serum.

Recent studies have investigated the in-

hibition of serum carbo xylesterase

by specific compounds causing an

i ncrease in malathion toxicity (Mallipudi

et al . , 1980 and Umetsu.

et al., 1981).
Townsend and Carlson (1981) showed mice pretreated with halogenated
benzenes

responded to malathion treatment with increased levels of

carboxylesterase activity in the liver and serum.

This suggested that

the increase in serum carboxylesterases may be due to a change occuring
in the liver.

Talcott and Ketterman (1 981) s howed that t hese serum

level s of malathion carboxylesterase may fluctuate due to s tructural
changes i n t he l iver end op l asm i c r et ic ulum .

They showed t hat serum

ma lat hio n car boxylesterase lev e ls were hig hly correlated with SGOT
and the highest titer was seen in a per so n overdosed with acetamin ophen.

These results suggested that serum levels of malathion carbox-

ylesterase may increase due to hepatic necrosis, allowing for another
serum assay to be used in asessing liver dysfunction.
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Voles
Voles are small mammals in the Order Rodentia and Family Cricetidae.

They are abundant and found in most habitat types.

Voles are

considered herbivores, consuming grasses, seeds, and some insects.
Voles have been used in microcosm exposure studies to evaluate
the residues of pesticides in model ecosystems.
used the prairie

Cole et al. (1976)

vole, Microtus ochrogaster in model ecosystems con-

taining water, soil, growing corn and various invertebrates.

The self-

contained environments were exposed to aldrin, DDT, fonofos or methoxychlor.

Residues of aldrin and DDT were larger than those of fonofos

or methoxychlor in the vole.

Levels of DOE were greater than DDT in

the vole, whereas the rest of the ecosystems showed DDT to be higher.
This indicated that the prairie vole has the ability to metabolize DDT
to ODE.

Further studies on the metabolic capabilities of the vole were

not conducted.
Studies by Gile and Gillett (1977) showed residue levels in~canicaudus, grey-tailed vole, of some of the insecticides they tested.
They used microcosm chambers that contained a soil medium, agricultural
crops, invertebrates and~- canicaudus.
EPA showed interest in microcosm exposure studies and felt the
vole was well suited to use in the microcosm chambers (Witt et al.
1977).

This was based on the ease of handling and rearing of the ani-

mals, as well as their behavior seemed suitable for the microcosm
chamber.

The EPA felt a need for more information on the behavior,

physiology and biochemistry of the vole.
There has been considerable work done on the pine vole, Pitymys
pinetorum and its resistance to endrin.

Endrin was used in apple or-
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chards for control off. pinetorum for many years and certain populations developed, where endrin became less effective.
(1967)

Webb and Horsfall

reported a resistant strain of pine voles having 12-fold

greater tolerance than the susceptible strain.

They felt it was an ac-

quired resistance caused by many years of endrin exposure.
Webb et al. (1972) showed the resistant pine vole to have greater
levels of hepatic benzpyrene hydroxylase activity than the susceptible
group.

They concluded this difference may be genetic as well as an in-

creased inductive potential of endrin.

Following this, several studies

were conducted over the next few years to investigate the resistant
capabilities of the pine vole.
In 1973, Hartgrove and Webb studied the activity of hepatic benzpyrene hydroxylase in various ages of susceptible and resistant pine
voles.

The resistant voles developed the ability to metabolize benz-

pyrene more rapidly and the levels of hydroxylase activity were always
higher in the resistant strain.

This further indicated a genetic basis

for endrin resistance.

Webb et al. (1973) showed F offspring of resis1
tant voles had higher Lo 50 values than susceptible and F1 of a cross
between resistant and susceptible voles were more susceptible to endrin
yet still more tolerant than the susceptible F offspring. Cross re1
sistance to dieldrin was seen but did not occur with Gophacide, an organophosphate, or the anticoagulant chlorophacinone.

The resistant

voles LD 50 values were lower than the susceptible voles fdr Gophacide
and chlorophacinore. Webb et al. (1973) believes this is due to increase in metabolic activation of these compounds in the resistant over
the susceptible strain.
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Petrella and Webb (1972) and Petrella et al. (1974) showed higher
excretion rates and an increased metabolism of 14 c-endrin in the resistant pine vole, compared to the susceptible vole.

Hartgrove et al.

(1972) reported ethylmorphine ~-demethylase activity was higher in endrin resistant voles than the susceptible and that aniline metabolism
did not show the correlation.
At the thirteenth annual meetings of the Society of Toxicology, 3
studies were presented dealing with the pine voles.

Hartgrove et al.

(1974) showed that phenobarbital caused an increase in microsomal activity of aniline hydroxylase and ethylmorphine !i-demethylase in both
strains to an equal degree.

The P-450 content also increased in both

strains.

Endrin treatment did not show this inductive effect in either

strain.

Hayes et al. (1974) showed that the binding kinetics of endrin

was not significantly different in the 2 strains of pine voles.

Hund-

ley et al. (1974) reported no difference in endrin concentration in
pups of dams treated with endrin, between the resistant and susceptible
voles.

Susceptible pups exposed to endrin through the dam's milk showed

a lower microsomal enzyme activity than the resistant pups.

This shows

that the resistant strain is still less susceptible to endrin at a
very young age than the susceptible strain.
The hepatic monooxygenase activity of endrin-resistant and
-susceptible pine voles were characterized by Hartgrove et al.
(1977).

They used ethylmorphine, aniline and benzo(a)pyrene as sub-

strates and also measured the cytochrome P-450 content.

Results of

the 2 strains were compared against the activity of ICR white mice.
No significant differences between the 2 strains of voles were seen in
the control groups although the levels were higher for the 3 substrates
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in the resistant animals.

The endrin treated groups showed varying

results depending on the substrate used.

The ethylmorphine B-demethylase

and benzpyrene 3-hydroxylation decreased in activity in endrin treated
voles for both strains.

Aniline hydroxylase and benzpyrene Vmax levels
showed increasing trends in both strains of voles when endrin was a
pretreatment.
The white mice showed different levels of enzyme activity compared
to the 2 strains of voles.

Endrin pretreatment caused an increase in

ethylmorphine ~-demethylation and aniline hydroxylase activity but a
decrease in benzpyrene Vmax and 3-hydroxylation.
Cytochrome P-450 content was higher in the resistant strain of
voles.

Endrin treatment of the mice and both strains of voles showed

an increase in cytochrome P-450 content.
Hartgrove et al. (1977) present some interesting work.

They il-

lustrate species differences as well as substrate specificity and differences in the hepatic monooxygenase activities of 2 strains of pine
voles and white mice.
Brindley (1979) saw varying effects on hepatic monooxygenase activities in Microtus canicaudus, the grey-tailed vole.

The inductive

effects on £-nitroanisole-Q-demethylase and aniline hydroxylase varied
depending on the inducer pretreatment of either phenobarbital or
B-naphthoflavone.
Makary (1981) characterized biphenyl hydroxylation in hepatic
microsomes of Microtus montanus (mountain vole).

This activity was

compared to biphenyl hydroxylation seen in Swiss white mice.
control animals, 4-hydroxybiphenyl

In the

was the major metabolite in both
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species, but all the Qydroxy metabolites were produced in higher concentrations in the mice than in the voles.

Pretreatment with pheno-

barbital (PB) showed significant increases of 2-, 3-, and 4-hydroxybiphenyl in the mountain voles.

Mice showed an inducti on in 3- and 4-

hydroxybiphenyl with treatment of PB .

Voles pretreated with

B-naphthoflavone or 3-methycholanthrene showed slight increase of all
3 metabolites, whereas mice showed higher induction in 2-hydroxybiphenyl over 3- and 4-hydroxylation. The results of this study showed a
definite species difference between white mice and mountain voles in
their hepatic monooxygenase system.
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MATERIALS AND METHODS
Animals
Female Microtus montanus (mountain vole) 8-12 weeks of age, were
obtained from the Department of Biology, University of Utah, Salt Lake
City, Utah.

The animals were kept at the Utah State University animal

care facility, 5 voles per plastic cage containing wood chips and cotton
batting.

The voles were acclimatized for at least 7 days to the housing

conditions of 20°C and a 12-hour photoperiod per day.

Intermountain

Farmers Association rabbit pellets and water were provided ad libitum.
Chemicals
Pretreatment compounds
Sodium phenobarbital, crystalline powder, was obtained from Merck

& Co., Inc. (Rahway, N.J.) and dissolved in 0.85% NaCl.

B-naphtho-

flavone was purchased from Aldrich Chemical Co. (Milwaukee, WI), and
Aroclor 1254 from Analabs (North Haven, Conn.).

Both compounds were

dissolved in Wesson vegetable oil.
Protein and liver enzyme assays
Coomassie Brilliant Blue G, used for the protein assay, and bovine
serum albumin used in the standard curve, were supplied by Sigma
Chemical Co. (St. Louis, Mo).

NADP+, NADPH, cytochrome C (prepared

from horse heart), sodium D, L~isocitrate, isocitrate dehydrogenase,
p-nitrophenol spectrophotometer standard, and Tris buffer (pH 7. 7) were
also obtained from Sigma Chemical Co. (St. Louis, Mo).

Aniline
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analytical reagent and sodium hydroxide were purchased from Mallinckrodt
Chemical Works (St. Louis, Mo), and trichloroacetic acid was obtained
from Fisher Scientific Co. (Fair Lawn, NJ).

J. T. Baker (Phillipsburg,

NJ) supplied _p-nitroanisole, _2-aminophenol, potassium cyanide, crystalline phenol, sodium carbonate, and magnesium chloride.
Serum enzyme assays
Alcohol dehydrogenase, B-NAD, a -hetoglutaric acid, _p-iodonitrotetrazoluim violet, pyruvic acid, and the chemicals used in the buffer
solutions were purchased from Sigma Chemical

Co. (St. Louis,' Mo).

Aldrich Chemical Co. (Milwaukee, WI) supplied 2,-3 -dinitrophylhydrozine.

Benzene and d,l-alanine were obtained from Fisher Scienti-

fic Co. (Fair Lawn, NJ).

The other solvents used in the column and

thin layer chromatography procedures were purchased from J. T. Baker
Chemical Co. (Phillipsburg, NJ).

Technical malathion 94.2 % pure was

donated by the American Cyanamid Co. (Princeton, NJ).
Hepatic Enzyme Assay Procedure
Voles received intraperitoneal injections of either sodium phenobarbital (PB) in 0.85% saline solution, B-naphthoflavone (BNF) dissolved in oil or Aroclor 1254 (PCB), also in oil.

Levels of pre-

treatment for PB groups ranged from 5 mg/kg body weight up to 100 mg/kg,
whereas BNF and PCB groups ranged from 5 mg/kg to 80 mg/kg.

The dosing

schedule consisted of 3 injections, 24 hours apart with a solution
volume of 10 ml/kg body weight.

The animals were sacrificed 24 hours

after the last injecti.on of PB and 48 hours for BNF and PCB.

The re-

sults of the treatments were compared to control animals that received
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the same number of injections of saline or oil only.

Food and water

were allowed ad libitum throughout the pretreatment schedule, until
time of sacrifice.

To prevent any fluctuations in enzyme activity due

to circadian rhythm, the injections and sacrificing occurred at the same
time between 8 and 10 a.m.
Liver microsomal preparation
Microsomes were prepared by the methods of Hartgrove
The voles were sacrificed by decapitation.

et al. (1977).

Gall bladders were cut away

and livers were removed, weighed, checked grossly for pathological signs,
and placed in small beakers surrounded by ice.

The remainder of the

liver preparation occurred on a cold table keeping the temperature between 0-4°C.

Livers were minced with a razor blade and homogenized in

5 ml of cold 1.15% KCl.

The homogenate was brought to a volume of 12 ml

with the KCl, and the cells were further disrupted using a Biosonik III
sonicator (Bronwill Scientific, Rochester, NY).

The homogenate received

three 5-second bursts at the 10-W setting with 15-seconds between each
burst.

The homogenate was centrifuged at 9,000 g for 20 minutes and

the supernatant was run at 30,000 rpm (105,000 g) for 75 minutes.
Centrifugation was performed in a Beckman L5-65B refrigerated ultracentrifuge with a type-30 rotor.

The microsomal pellet was washed with

1 ml 1.15% KCl in 0 . 02 M Tris buffer (pH 7.7) and resuspended in 5 ml of
the same buffer by gentle homogenization.
Protein determination
Protein levels were measured by the method of Bradford (1976).
The protein reagent consisted of 100 mg Coomassie Brilliant Blue G and
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50 ml 95% ethanol shaken for at least 2 hours.

After shaking, 100 ~l

85% phosphoric acid was added and the solution was diluted with water to
a final volume of 1 liter.
use.

The protein reagent was filtered before each

Standard curves were constructed for each reagent mixture, using

known concentrations of bovine serum albumin.
The resuspended microsomes in 5 ml of Tris-KCl buffer (pH 7.7) were
diluted by taking 1 ml and bringing it up to a volume of 4 ml with the
Tris KCl buffer for a final dilution of 1:20.

Each microsome sample

was further diluted 20, 25 and 30 fold with Tris KCl buffer.

Aliquots

of 0.05 ml of these 3 dilutions were placed in separate test tubes.
Each tube received 5 ml of filtered Coomassie Blue reagent and mi xed
gently.

As a result, each liver sample was read in triplicate for pro-

tein at three different concentrations.
The absorbance was measured after 2 minutes and before 1 hour on
a Zeiss PMQ-11 spectrophotometer set at 595 nm and slit width 0.07.
Samples were read against a standard consisting of 0.5 ml Tris buffer
and 5 ml protein reagent.

The optical densities were converted to pro-

tein concentrations using the standard curve.
Aniline hydroxylase assay
The microsomal activity of aniline hydroxylase was determined by
the formation of p-aminophenol as described by Imai

et al. (1966).

This method was easier to run and involved less time than the ether extraction procedure by Kato and Gillette (1965).

Chhabra

et al. (1972)

demonstrated that Imai s method provides higher recovery of p-amino1

phenol when liver microsomes are used as an enzyme source compared to
the ether extraction procedure.
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A suitable volume of the 1:5 dilution microsome solution was used
to obtain a protein level between 0.6 to 1.2 mg protein per incubation.
This provided a linear relationship between protein concentration and
rate of reaction.

The volume of the tissue solution was placed in a

test tube and brought up to 0.6 ml with 1.15% KCl in 0.02 M Tris buffer
(pH 7. 7). Added to this was 0.2 ml

of the NADPH-generating system.

The reaction was started by adding 0.2 ml of an aniline stock solution
making the final volume of the reaction mi xture 1 ml, and containing
8 m moles of aniline.

The reaction was carried out for 20 minutes at

37 °C in a water bath with moderate shaking and stopped by the addition
of 0.5 ml cold 20% trichloroacetic acid.

Each sample was run in tripli-

cate.
The mi xture was centrifuged at 2,000 rpm for 5 minutes and 1 ml
aliquot of the supernatant was removed.

To this was added 0.5 ml 10%

Na 2C0 3 followed by 1 ml 2% phenol in 0. 2 N NaOH.

The resulting blue

color was measured after 30 minutes on the Zeiss PMQ-11 spectrophotometer set at 630 nm, and slit width 0.15.

The absorbance was measured

against a cuvette containing only Tris-KCl buffer.

The optical densi-

ties were compared to the standard curve constructed from known amounts
of .2_-aminophenol.
Each 1 ml of NADPH generating system contained stock solutions of
0.32 ml

MgClz•6H20 (0.4g. in 100 ml),0.32 ml sodium DL-isocitrate

(0.9gin 100 ml), 0.0182 ml isocitrate dehydrogenase, 0.00056 g NADP+,
and enough water to bring it up to the volume of l ml.

The system was

checked for the production of NADPH by the increase in optical density
c1 t 340 nm
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~-Nitroanisole-0-demethylase assay
p-Nitroanisole-0-demethylase activity was measured by the formation
of p-nitrophenol by the methods of Kinoshita

et al. (1966).

The stock

solution of p-nitroanisole (PNA) contained 0.07 g PNA in 2 ml 100%
ethanol and 8 ml ethylene glycol.

The glycine buffer solution contained

0.5 M glycine titrated to pH 9.4 with saturated Na0H.
For each liver sample,0.05, 0.1 and 0.2 ml of the 1:20 dil tissue
solution were put in 3 test tubes.

Each tube was brought up to 0.4 ml

with 1.15% KCl in 0.02 M Tris buffer and 0.2 ml NADPH generating system
was added.

The NADPH generating system used for aniline hydroxylase

was also used for the PNA assay.

A volume of 0.5 ml stock PNA solution

was mixed with 5 ml of the Tris-KCl buffer and remained warm in a 37°C
water bath.

This prevented any precipitation of the substrate PNA.

The reaction started when 0.2 ml of the warm PNA was added to each test
tube.

The mixture incubated for 15 minutes at 37°C with moderate shaking.

Cold acetone, 2.5 ml, was added to each tube to stop the reaction.

The

tubes were corked and allowed to reach room temperature.
Each tube received 0.2 ml

of the glycine buffer solution and the

precipitates were separated by centrifuging at 2,000 rpm for 10 minutes.
The yellow color was read at 410 nm on the Zeiss spectrophotometer and
slit width 0.15.

The absorbance was measured against distilled water

and the optical density was converted to concentration of p-nitrophenol
using a standard curve.
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Cytochrome C reductase assay
Hepatic microsomal cytocrome C reductase activity was measured by
the modification of the method of Dallner (1963).

For every 4 assays,

8.712 mg of cytochrome C and 0.95 mg of NADPH were dissolved in 8 ml
1.15% KCl in 0.02 M Tris buffer (pH7.7). KCN, 0.304 mg, was dissolved
in 4 ml Tris KCl buffer.

These 2 stock solutions were made just prior

to running the assay.
The procedure consisted of pipetting 0.05, 0.1 and 0.2 ml of the
1:20 tissue dilutions into 3 test tubes.

These tubes were brought to

a volumeof0.5 ml with Tris KCl buffer.

A volume of 1.0 ml KCN stock

solution was added to each tube.

Just prior to reading a sample, 2 ml

of the cytochrome C and NADPH solution were added to the test tube.

The

production of reduced cytochrome C was observed on the Zies spectrophotometer (550 nm).
and 60 seconds.

Optical densities were recorded at time 0, 10, 20

The concentration of reduced cytochrome C was calcu-

lated by using Beer's Law and the extinction coefficient of 21000 cm 3/M
at 550 nm .
Serum Enzyme Assay Procedure
Female voles received the same pretreatment schedule as described
under the hepatic enzyme assay procedure.

A high, low and middle dose

were used for each chemical except carbon tetrachloride.

The doses in-

cluded 5, 50, or 80 mg/kg body weight of sodium phenobarbital.

B-

Naphthoflavone and Aroclor 1254 were given at 5, 40, or 80 mg/kg.
Carbon tetrachloride was given by 1 injection of 0.1 ml /kg.
were compared to controls of oil or saline.

Results

The animals were sacrificed
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and blood collected by decapitation.
weighed and gross appearance noted.

Gall bladders were removed, livers
A section from the lower left lobe

of the liver was placed in 10% neutral buffered formalin for histopathology examination.
Serum was collected by leaving the blood at room temperature for
1 hour, then refrigerated for 30 minutes, followed by centrifuging on
a Triac centrifuge, ~lay Adam~ for 5 minutes.
varied from 0.2 ml to 0.4 ml.

Serum volumes collected

The serum samples were diluted

1:5 for

the serum transaminase assay using 0.1 M phosphate buffer (pH 7.4).

A

dilution of 1:100 for malathion carboxylesterase and 1:1,000 for the
protein assay was achieved by adding 0.1 M Tris HCl buffer (pH 7.5).
Protein determination
Protein of serum samples was determined by the method
(1976).

of Bradford

The samples were diluted 1:1,000 with the 0.1 M Tris HCl buffer

(pH 7.5) and 0.05 ml of this solution was mixed with 5 ml of the protein
reagent.

Each sample was run in triplicate.

The rest of the procedure

was the same as outlined under the protein determination for hepatic
microsomes.
Serum glutamic pyruvic transaminase
In this reaction, an amino group from alanine is transfered to
a-ketoglutaric acid to form glutamic acid and pyruvic acid.

The assay

was conducted by the methods of Reitman and Frankel (1957).

The volumes

used in the assay were 1/2 that described by Reitman because of the
small quantities of serum obtained.

There was no change in enzyme

activity due to this reduction of the reactants.
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The 0.1 M phosphate buffer system (pH 7.4) was prepared by mixing
420 ml 0.1 M disodium phosphate with 80 ml 0.1 M potassium dihydrogen
phosphate.

The substrate solution consisted of 2 mM

a-ketoglutarate

and 200 mM Q}_-alanine brought to volume with the phosphate buffer.
The substrate solution, 0.5 ml, was incubated with 0.1 ml of the 1:5
diluted serum for 30 minutes at 40°C with mild shaking.

The substrates

were warmed in the water bath for 10 minutes prior to the start of the
reaction.

The reaction was stopped by adding 0.5 ml of 12, 4-dinitro-

phenylhy~razine.

The mixture remained at room temperature for at least

20 minutes before 5 ml of 0.4 N sodium hydroxide was added.

At the

end of 30 minutes, the optical density was measured at 505 nm on the
Ziess spectrophotometer with the slit width 0.04; using water as a
blank.
A control for each serum sample was prepared by mixing 0.5 ml
substrate, 0.1 ml dilute serum, and 0.5 ml

of the hydrazine reagent.

After a minimum of 20 minutes, 5 ml of 0.4 N sodium hydroxide was added
and the optical density of the solution was measured as mentioned with
the incubated mixture.
The change in optical density was calculated by subtracting the
optical densities of the control value from the corresponding incubated
value.

This change in optical density was converted to micromoles of

pyruvate using the prepared standard curve.

This value was then

converted to units of transaminase activity, using the standard curve
supplied by Reitman and Frankel (1957), which was based on the units
described by Karmen (1955}.

This is sho~n in Fi~. 2.

The standard curve plotting change in optical density against
micromoles of pyruvate, was prepared by mixing known amounts of 2 mM
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a-ketoglutorate solution and 2 mM

pyruvate solution, making a total

concentration of keto acid, to be 2 mM per 1 ml.

Added to this was 0.1

ml water; the hydrazine reagent and alkali were added as described in
the procedure above.
Malathion carboxylesterase
Serum malathion carboxylesterase assay was based on the methods of
Talcott (1979).
ethanol.

Malathion is hydrolyzed to form malathion monoacid and

Alcohol dehydrogenase converts the ethanol and NAO to aceta-

ldehyde and NAOH.

The NAOH plus diaphorase reduced .e_-iodonitrophenyl-

tetrazolium violet (INT) and this reduction could be measured spectrophotometrically.
The reduction of INT was measured at 500 nm on the Ziess PMQ-11
spectrophotometer.

Water was heated and passedaroundthesample chamber

to keep the chamber at 37°C during the incubation.

The assays were

done in cuvettes containing 2.5 ml of incubation mixture.

This mixture

contained 0.6 ml of the 1:100 diluted serum, making a final dilution in
the reaction to be 1:4175.

The serum and other reactants were in a

0.1 M Tris HCl buffer (pH7.5).

The incubation mixture also contained

437 Ug/ml INT, 25 U/ml alcohol dehydrogenase, 1.8 mM
U/ml NAO diaphorase.

NAO, and 0.1

The reactions were started by injecting 5 ul of

150 mM malathion (in acetone) into the cuvette and mixed by inversion.
The incubation mixture began reacting after 2 minutes in the 37°C
temperature.

The change in optical density was recorded every 30 sec-

onds for the next 3 to 4 minutes.

The malathion carboxylesterase

activity, equivalent to the INT reduction rate, was calculated using
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Beer's law and the extinction coefficient of 0.01375 A500/µM

as

determined by Talcott (1979).
The malathion used for the assay was purified by column chromatography by the modified methods of Pellegrini and Santi (1972).

The

column chromatography was performed in a glass column (inside diameter
2 cm,height 45 cm), eluting malathion with 90:10 n-hexene:acetone.
Malathion was eluted in the 160 to 240 ml fraction.

The column was

packed with 40 g of silica gel 60 from MC/B Manufacturing Chemists,
Inc. (Cincinnati, OH), having a mesh of 70 -230.
The above procedure increased the purity of malathion to 98.2%
pure (Pellegrini and Santi, 1972).

This was checked by thin layer

chromatography using the methods of Umetsu et al. (1977).

Precoated

plates of Kontes Chromaflex Q6F measuring 5 x 20 cm were used with
ben ze ne.

The l oc ation of the compounds were determined by ultravi olet.

Most of the impurities were removed by the column chromatography,
with only small quantities remaining.
(0.5-0.55) of
(1977 ).

This corresponded to the RF

3 2

(CH □) P(S)SP(S)

(OCH ) 2 as found in Umetsu et al.
3
This compound had little interference if any in the malation

carb ox ylestaerase assay.
Hepatic Histological Procedure
Tissues used for the histopathology were kept in 10% neutral
buffered formalin until needed for sectioning.

The histological

slides were prepared by the Veterinary Diagnostic Laboratory (log
number L82-1401) and stained with hemato xylin and eosin.

The
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tissues were viewed under a light microscope and observations were
recorded.
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RESULTS
General Effects on Animals and Livers
Animals pretreated with phenobarbital (PB) in the 20 and 50 mg/kg
range, appeared sedated while 5 mg showed no effects and 80 and 100
mg induced sleep.

Aroclor 1254 (PCB) and B-naphthoflavone (BNF) showed

no adverse behavioral effects.

Carbon tetrachloride-treated animals

at doses of 1 or 2 ml/kg died, while 0.1 ml/kg caused lethargy
and the animals were severely stressed due to the to xicity of the
compound.
Average body weights and liver weights of PB, BNF, and PCB and
the control animals are shown in Table 1.

The ratio of liver weight

t o body weight increased significantly (P<0.01) in the higher doses of
PB and 80 mg PCB over the controls of saline and oil respectively.

No

significant difference (P< 0.01) was seen in the BNF pretreatment
groups compared to oil (Table 1).

The ratio of microsomal protein to

liver weight varied according to type of inducer and dose of pretreatment as illustrated in Table 1.
Effect of Hepatic Microsomal Enzymal Activity
by PB, BNF and PCB
The mean changes in microsomal enzyme activity of aniline hydroxylase, £-nitroanisole-_Q_-demethylase and cytochrome C reductase are shown
in Table 2.

The enzyme activity varied according to the type of inducer

and the pretreatment dose.

Following Table 2, the results are grouped
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Table 1.

Effect of pretreatment injection upon liver weights, liver
weight to body weight and microsomal protein of female voles.

n

Body Wt.
(g)

Liver Wt.
( g)

mg Liver/
g Body Wt.

mg
Microsomal
Protein/
g liver

Control

5

28.2 ± 3.6

1.10 ± 0.37

38. 5 ± 9.5

33.7 ± 3.7

Saline

8

30.0 ± 3.2

1.09 ± 0.16

35.9 ± 6.1

25.1 ± 2.5*

PB

5
4
5
4
5

34.7
31. 9
33.8
38.0
25 .8

1.44
1.42
1.61
1.87
1.58

41.3
45.0
47.0
48.8
60.8

5

25.3 ± 2.7

Pretreatment
mg/kg

5
20
50
80
100

OIL

±
±
±
±
±

3.8
4.8
8.3
8.9
3.5

± 0.30
0.36
± 0.54
± 0.52
± 0.38

±

0.82 ± 0.06

± 7.1
± 11.9
± 4.7*
± 3.3*
± 7.9*

32.6 ± 2.8

22.8
21. 7
36.3
33.7
32.1

±
±
±
±
±

4.7
6.4
3.9*
3.5*
3. 6*

25.4 ± 2.8*

BNF

5
20
40
50
80

5
5
5
4
5

33.5
29.3
25.3
35.8
30.4

±
±
±
±
±

11.4
3.2
4.0
9.5
2.0

1.25
0.98
0.84
1.23
1.06

±
±
±
±
±

0.28
0.16
0 .11
0.43
0.07

38.5
33.4
33.3
33.9
34.9

±
±
±
±
±

7.1
2.7
2.4
2.9
2.3

16.8
12.3
23.3
27.9
15.8

±
±
±
±
±

1.4*
2.6*
3.6
4.7
3.3*

PCB

5
10
20
40
80

5
5
5
5
5

29.4
31.4
27.9
29.7
31. 9

±
±
±
±
±

4.4
6.0
1.6
3.8
1.2

0.84
1.10
0.87
1.15
1.25

±
±
±
±
±

0.16
0.19
0.12
0 .13
0.17

28.7
35.3
31.3
39.6
39.1

±
±
±
±
±

3.5
3.3
4.2
8.7
4.1*

23.9
22.0
27.5
27.5
23.0

±
±
±
±
±

2.5
2.3
2.2
5.9
6.8

Results are mean ± standard deviation.
*Indicates significant difference ( p < 0. 01 ) •

Table 2.

Variation in enzyme activity due to type and does of inducer in voles.

Pretreatment
mg/kg

n

Aniline
Hydroxylase*

Control

5

0.056

± 0.005

0.052 ± 0.01

84.8

± 10 .1

Saline

8

0.046

± 0.015

0.038 ± 0.015

83.0

± 15.7

PB

5
5
5
4
5

0.066
0.132
0.126
0.177
0.138

±
±
±
±
±

0 . 013
0.04
0.009
0.030
0.020

0.058
0.063
0.074
0.105
0.145

±
±
±
±
±

0.008
0.02
0.011
0.013
0.032

111. 5
162. 81
121. 3
143 . 6
228 .1

0i l

5

0.0631 ± 0.010

0.059

:!:

0.016

BNF 5
20
40
50
80

5
5
5
4
5

0.067
0.073
0.087
0.087
0.095

±
±
±
±
±

0.018
0.047
0 . 015
0.025
0 . 032

0.034
0.055
0.072
0.061
0.095

±
±
±
±
±

0.012
0.010
0.014
0.022
0.023

147 . 1
260.7
130.4
88.5
153.4

±
±
±
±
±

28.5
80.8
19.8
26. 8
27 .8

PCB 5
10
20
40
80

5
5
5
4
4

0. 085
0.046
0.075
0.058
0.077

±
±
±
±
±

0.019
0.004
0.015
0.013
0.026

0.045
0.082
0.069
0.038
0.050

±
±
±
±
±

0 .011
0.014
0.005
0.013
0.005

124.0
102. 7
97.3
84.4
93.3

±
±
±
±
±

13.3
13.0
10.5
19.9
9.8

5
20
50
80
100

p-Nitroani sole
-=-_g_-demethylase*

Results are mean ± standard deviation
* Indicates µ moles/mg protein - min.
** Indicates n moles/mg protein - hr.

Cytochrome C
Reductase**

±
±
±
±
±

11.8
37
6.8
26.5
19. 8

97 . 4 ± 18. 5
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by the different substrates used to determine monooxygenase activity.
Graphical respresentation of the enzyme activity for the 3 inducers

at

various doses, is followed by a table illustrating the significant differences.

The lines in the graph are smoothed to pass through each mean

activity value at the corresponding dose of inducer.

The significant

differences of enzyme activity in the same pretreatment group, but
varying the dose; and the differences between the inducers at the same
dose were calculated by multi-way AN0VA (P

<

0.05).

In the AN0VA

tables, (+) indicates a significant difference while (-) indicates no
significant difference at P

<

0.05.

Increase and decrease differences

are represented by I and D respectively.

The increase and decrease are

determined by the change in activity of the pretreatment dose on the
horizontal axis compared to dose on the vertical axis.
Aniline hydroxylase
Figure 3 illustrates the change in enzyme activity
droxylase, due to the dose of inducer PB, BNF, or PCB.

of aniline hyPB shows an

increase at the dose of 20 mg/kg and leveling off until a dose of 80
mg/kg increases the activity.

Significant differences (SD) are shown

in Table 3, and support the plateau effect since 20 and 50 mg/kg are SD
over the control and 5 mg; yet no SD occured between 20 mg and 50 mg.
The dose of 80 mg of PB causes a significant increase in activity over
all the lower doses while 100 mg/kg decreases activity compared to 80
mg and is not SD from 20 or 50 mg/kg.
BNF shows a slow, steady increase of enzyme activity with increased pretreated doses (Figure 3).
as shown in Table 3.

But these activities are not SD

The changes in activity due to PCB pretreatment
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Table 3.

Results of ANOVA in microsomal enzyme activity of aniline
hydroxylase.

I.

No significant difference between control, saline, or oil.

I I.

Differences in same pretreatment groups varying the dose:
PB 5 mg
Saline
PB 5 mg
20 mg
50 mg
80 mg

III.

20 mg

50 mg

80 mg

100 mg

+I
+I

+I
+I

+I
+I
+I
+I

+I
+I
+D

BNF

no significant differences in varying the dose.

PCB

no significant differences in varying the dose.

Differences between the 3 pretreatment groups of the same dose:
5
20
40 + 50
80

mg;
mg;
mg;
mg;

no significant differences
no significant differences
PB 50 (+I) over BNF 40 which is (+I) over PCB 40
PB 80 (+I) over BNF 80 and PCB 80; but no significant
difference between BNF 80 and PCB 80.

(+) indicates significant difference (P < 0.05)
(-)indicates no significant difference (P < 0.05)
I -- increase; D -- decrease; I and Dare determined by comparing the
results of the horizontal axis pretreatments to the vertical.
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showed fluctuation as seen in Figure 3, yet the activities were not SD
determined by AN0VA (Table 3).
Differences between the 3 inducers on aniline hydroxylase activity
at the same dose level were calculated and results shown in section III
of Table 3.

PB at 50 mg caused an increase SD of enzyme activity over

BNF at 40 mg which was also SD over PCB at 40 mg.

PB of 80 mg pre-

treatment was significantly higher than the effect of BNF and PCB at 80
mg, but no differences between BNF and PCB at 80 mg.
_g-~li troani so 1e-_Q_-demethyl ase ( PNA)
The changes in PNA activity are illustrated in Figure 4 with the
ANOVA shown on the following page in Table 4.

The effects of increasing

the dose of PB pretreatment caused an increase in PNA activity.
Starting at the dose of 20 mg/kg and continuing up to 100 mg/kg, all
the doses were

significantly different (SD) from controls and each

higher dose was SD than the lower doses (Table 4).
Pretreatment with BNF at 5 mg/kg led toa significant decrease i n
activity over the control, whereas
from the controls.

20, 4G, and 50 mg/kg were not SD

This is shown in Figure 4 and Table 4.

Pretreat-

ment of 80 mg/kg of BNF produced a significant increase in PNA activity
over controls and all lower doses.
PCB pretreatment resulted in a significant increase in hydroxylase
activity at low doses of 10 and 20 mg/kg, but a significant decrease in
activity at 40 and 80 mg/kg.

Although, 80 mg/kg was not SD over the con-

trol, it was SD compared to dose levels of 10 and 20 mg/kg.
At the level of 5 mg/kg, BNF had an effect of decreasing PNA activity which is SD over the effects of PB and PCB.
found at the level of 20 mg/kg

There was no SD

between PB, BNF, and PCB.

Pretreat-
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Table 4.

I.

II.

Results of ANOVA in microsomal enzyme activity of
..e_-nitroanisole-Q-demethylase.

No significant differences between control, saline, and oil.
Differences in same pretreatment groups varying the dose:
PB
Saline
PB 5 mg
20 mg
50 mg
80 mg
BNF
OIL
BNF 5 mg
20 mg
40 mg
50 mg
PCB
OIL
PCB 5 mg
10 mg
20 mg
40 mg

III.

5 mg

20 mg
+I

50 mg
+I
+I
+I

80 mg
+I
+I
+I
+I

100 mg
+I
+I
+I
+I
+I

mg

20 mg

40

mg

50 mg

80 mg
+I
+I
+I
+I
+I

5

+D
+I

5 mg

10 mg
+I
+I

20 mg

+I

40

mg

80 mg

+D
+I
+D
+D

+D
+D

Differences between the 3 pretreatment groups of the same dose:
5
20
40 + 50
80

mg;
mg;
mg;
mg;

BNF (+D) compared to PB and PCB.
no significant differences.
PB 50 and BNF 40 are both (+I) over PCB 40.
PB and BNF are both (+I) over PCB.

(+) indicates significant difference (P < 0.05)
(-) indicates no significant difference (P < 0.05)
I -- increase, D -- decrease; I and Dare determined by comparing the
results of the horizontal axis pretreatments to the vertical.
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ment of PB at 50 mg/kg and BNF at 40 mg/kg produced a significant increase in PNA activity over PCB at 40 mg/kg.

Again, at 80 mg/kg, the

effects of PB and BNFwere significantly higher than the effects produced
by PCB.
Cytochrome C reductase
Figure 5 illustrates the effects of PB, BNF, and PCB at various
doses, on cytochrome C reductase activity.
the reductase activity.

Table 5 shows the ANOVA of

PB produced a significant increase in activity

at all pretreated doses, compared to control.

The effect on the reduc-

tase activity increased except at 50 and 80 mg/kg which were significantly depressed compared to 20 mg.

Then at 100 mg/kg, the activity was

significantly higher then all the other doses.
The effects of BNFwere similar to that of PB.

The low doses of

5 and 20 mg/kg produced an increased SD over the controls as well as the
80 mg/kg treatment.

But the intermediate dose of 40 and 50 mg/kg pro-

duced an effect that is not SD than the control.

The highest reductase

activity with BNF pretreatment occured at 20 mg/kg.
Pretreatment with PCB showed a significant increase in reductase
activity at the level of 5 mg/kg only.

PCB doses of 10, 20, 40, and

80 mg/kg showed a difference in effect over control, yet each dose significantly depressed reductase activity compared to 5 mg/kg PCB.
At the level of 5 mg/kg, the reductase activity of BNF pretreatment, was significantly higher than the effect of PB, as shown in Table
5, section III.

Pretreatment at the 20 mg/kg dose showed BNF to be SD

over PB, which was SD over PCB.

PB at the dose of 50 mg/kg and BNF at

40 mg/kg produced a significant increase in reductase activity over PCB
at 40 mg/kg and this also occurred at the dose level of 80 mg/kg (Table
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Table

I.
II.

III.

5.

Results of ANOVA in microsomal enzyme activity of cytochrome
C reductase.

No significant differences between control, saline, and oil.
Differences in same pretreatment groups varying the dose:
PB
Saline
PB 5 mg
20 mg
50 mg
80 mg

5 mg
+I

BNF
Oil
BNF 5 mg
20 mg
40 mg
50 mg

5 mg
+I

PCB
OIL
PCB 5 mg
10 mg
20 mg
40 mg

5 mg
+I

20 mg
+I
+I

50 mg
+I

80 mg
+I
+I
+D
+I

100 mg
+I
+I
+I
+I
+I

40 mg

50 mg

80 mg
+I

+D

+D

+D

+D

20 mg
+I
+I

+I
10 mg

20 mg

40 mg

80 mg

+D

+D

+D
+D

+D

Differences between the 3 pretreatment groups of the same dose:
5
20
40 + 50
80

mg;
mg;
mg;
mg;

BNF (+I) over PB only.
BNF (+I) over PB which is (+I) over PCB 40.
PB 50 and BNF 40 both (+I) over PCB 40.
PB and BNF both (+I) over PCB.

(+) indicates significant difference (P < 0.05).

(-) no significant difference (P < 0.05).
I -- increase, D -- decrease; I and Dare determined by comparing the
results of the horizontal axis pretreatments to the vertical.
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5).

Percent change of hepatic enzyme activity
compared to control
The data from PB, BNF, and PCB effects on hepatic microsomal
enzyme activity in Table 2 were compared to the corresponding control
values.

The percent change in activity due to the dose and type of in-

ducer is presented in Table 6.
of the results from Table 6.

Figures 6-8 are graphical representation
These graphs indicate the trends of in-

duction potential of PB, BNF, and PCB at various doses on:

aniline

hydroxylase, ~-nitroanisole-Q-demethylase and cytochrome C reductase.
Aniline hydroxylase activity increased to 171-185% over the control at the medium range doses of 20 and 50 mg/kg PB; with 80 mg/kg PB
caused

a 282 % increase in activity.

BNF produced a slight increase in

hydroxylase activity at each higher dose, while 80 mg BNF caused a small
50 % change over control.

The percentage change that PCB produced, was

minimal compared to control values (Figure 6).
For -p-nitroanisole-0-demethylase,
PB produced an increase in percent change over control with each higher dose, showing 80 mg/kg PB to
cause a 174% increase (Figure 7).

Pretreatment of 5 mg/kg BNF caused

a 44 % decrease in activity while 80 mg resulted in a 60% increase.

The

percent change in demethylase activity due to PCBwassmall;whil ,2 5, 40,
and 80 mg/kg levels produced

a decrease.

Figure 8 shows the percent change from controls for cytochrome C
reductase activity.

PB produced an increase in percent change with the

highest increase, 96 %, occuring at 80 mg/kg.

BNF generated small per-

cent changes except at 20 mg/kg where the activity increased 168% over
the controls.

PCB created a decrease in percent change, except for the

Table 6.

Percent change from control of enzyme activities at various
pretreatment doses in voles.
Percent change from control

Pretreatment
(mg/kg)
PB

BNF

PCB

Aniline
Hydroxyl ase

.E_-nitroanisole
-_Q-demethyl ase

5
20
50
80

43
185
171
282

50
63
93
174

5
20
40
50
80

6
15
38
38
51

-44
- 8
22
3
60

5
20
40
80

34
20
- 8
22

-24
16
-36
-16

Cytochrome C
Reductase
34
(.;,

96

46
73

I}..-

51
168
34
-9
58
27
- 1
-13
- 4
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low dose of 5 mg/kg.
Serum Enzyme Levels of SGPT and
Malathion Carboxylesterase
Table 7 shows the results of serum glutamic pyruvic transaminase
(SGPT) and malathion carboxylesterase U1CE) levels due to pretreatment
of PB, BNF, and PCB at low, medium and high doses.

There was no sig-

nificant difference (SD) between the controls, saline, and oil in either
SGPT or MCE.
levels.

Table 7 also illustrates the . high variability in SGPT

PB at 5 mg/kg, 80 mg/kg of BNF, and 5 and 40 mg/kg of PCB all

produced a significant decrease in SGPT units (P

<

0.05).

Pretreatment

with 80 mg/kg PB and 5 and 40 mg/kg BNF produced a significant decrease
in SGPT units (P < 0.1 ).

MCE levels significantly decreased (P < 0.01)

with pretreatment doses of 5 and 50 mg/kg PB and 40 mg/kg PCB.

Carbon

tetrachloride, injected once, at O.l ml/kg produced a massive increase in SGPT units and serum MCE activity.
ment, showed significantly higher levels (P

Rats, with no pretreat<

0.05) of SGPT and MCE,

compared to the vole control group.
Gross Evaluation and Histopathology
of Liver Tissues
Samples of control liver tissues (no pretreatment)
with well delineated sinusoids (Figure 9).

appeared normal

Gross examination showed

saline injected voles appeared normal while the livers from the oil
group were greasy.

Histological evaluation revealed swelling and

slight vacuolization of hepatocytes diffusely throughout the lobule in
the saline group (Figure 10), with increased vacuolization in the oil
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Table 7.

Serum enzyme levels of SGPT and malathion carbo xylesterase
in the different pretreatment groups.

Malathion
Carboxylesterase
nmoles;
mg Prat-min

Pretreatment
mg/kg

n

SGPT Units

n

Control

4

99.5 ± 17.3

4

4.99 ± 2.6

Saline

4

96 .3 ± 45.9

4

4.0 ± 2.4

PB

3
4
2

30.0 ± 13.2**
65.0 ± 21.2
39.0 ± 4.2*

4
4
4

7. 8 ± 3.9*
9.9 ± 1.2*
4.7 ± 1. 9

4

60.0 ± 24. 8

4

8.8 ± 5.1

5
50
80

OIL
BNF

5
40
80

4
3
4

37.5 ± 17.1
31. 7 ± 12.6
31.3 ± 8.5**

2
2
4

11. 6 ± 0.7
4.6 ± 2.9
8.7 ± 6.4

PCB

5
40
80

3
3
2

6.7 ± 1.2**
8.2 ± 1.9**
36.0 ± 0

2
3
3

7.2 ± 4.2
4 .1 ± 2.3
7.4 ± 3.9

Carbon
Tetrachloride
0.1 ml/kg

4

1475 ± 275.4**

4

17.92 ± 3**

Rat -- no
pretreatment

2

157.5 ± 116.7

2

23.9 ± 0.6

Results are mean ± standard deviation.
*Indicates significant difference ( p < 0.10).
**Indicates significant difference ( p < 0.05).
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Figure 9.

Light micrograph
pretr atment.

of hepatic tissue from voles with no

Figure 10.

Light micrograph
with saline.

of hepatic tissue from voles pretreated

I
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injected voles.

I

The sinusoidal spaces were not as apparent compared to

the controls.
In general, the histological changes seen from the different inducers and dose levels were similar.

Cellular responses included acute

degeneration with lipid accumulation and vacuolated cytoplasm, primarily in the centrilobular regions.
in the hepatic tissues.

No inflarm1atory responses were seen

Using a system for ranking the tissue lesion

did not prove feasible because of the variations seen within the different dose levels.

Comments on the general trends of the liver changes

between the inducers and dose levels are presented below.
Gross examination of the PB treated voles showed no changes in the
5 mg/kg group, while the 50 and 80 mg dosed animals had enlarged livers.
Histological examination showed increased foamy and vacuolated centrilobular hepatocytes at the 5 mg/kg level.

This spread into the midzon-

al regions and increased in intensity with the 50 mg/kg groups (Figure
11).

At the highest dose of 80 mg/kg, some hepatic tissues appeared

similar to the 50 mg group; while other samples showed less vacuolation
and most cells becoming hypertrophied with enlarged nuclei.

This is

shown in Figure 12.
The livers from BNF treated voles, under gross examination, were
greasy in appearance at the 5 mg/kg dose with enlarged livers and
fibrin tabs present in the 40 and 80 mg dosed animals.

Histologically,

the livers appeared similar to that of PB pretreatment except the
changes did not follow at the same dose levels.

At the 5 mg/kg BNF

pretreatment group, some samples showed little change from the controls
and others had foamy and vacuolated centrilobular hepatocytes (Figure
13).

The same vacuolization effect was present in the 40 mg/kg group

I
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Figure 11.

Light micrograph of hepatic tissue from voles pretreated
with 50 mg/kg PB.

Figure .12.

Light micrograph of hepatic tissue from voles pretreated
with 80 mg/kg PG.
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Figure 13.

Light micrograph of hepatic tissue from voles pretreated
with 5 mg/kg BNF.

Figure 14

Light micrograph of hepatic tissue from voles pretreated
with 80 mg/kg BNF.
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and increased in the 80 mg/kg animals (Figure 14).

One tissue sample

from the 80 mg BNF had large hypertrophied cells similar to 80 PB, but
other samples resembled the 50 mg/kg PB group.
Gross examination of PCB treated voles showed greasy livers in
the PCB 5 groups whereas 40 and 80 mg/kg PCB produced livers that were
less greasy.

At the higher doses, an increase in fibrinous attachments

to gut viscera occurred.

At the 5 mg/kg dose, the hepatocytes

appeared extremely foamy and vacuolated throughout the lobule with the
greatest changes in centrilobular region (Figure 15).

Livers from the

group PCB 40, showed slightly foamy cells in the centrilobular region
and the rest of the tissue had swollen, hypertrophied hepatocytes.
The 80 mg/kg dose of PCB, showed a reduction in cells that were vacuolated and an increase in swollen hepatocytes (Figure 16), but not to the
same

degree seen in PB 80.
Gross examination of livers from carbon tetrachloride pretreated

animals, revealed dry, ischemic livers with petechiation of the surface.
Histologically, the tissue showed acute hepatic necrosis in the centrilobular and midzonal regions with no recognizable cell membrane or
nuclei in this area.

In the periportal regions, hepatocytes showed

severe fatty degeneration with extreme vacuolation (Figures 17 and 18).
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Figure 15.

Light micrograph of hepatic tissue from voles pretreated
with 5 mg/kg PCB.

Figure 16,

Light micrograph of hepatic tissue from voles pretreated
with 80 mg/kg PCB.
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Figure 17.

Light micrograph of hepatic tissue from voles pretreated
with 0.1 ml/kg carbon tetrachloride.

Figure 18.

Light micrograph of hepatic tissue from voles pretreated
with 0. l ml/kg carbon tetrachloride.

-

---
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DISCUSSION
This section is divided into two main areas to better interpret
the results.

The first section involves a discussion of the metabolic

changes occuring in the liver, due to various doses of PB, BNF and PCB.
The second topic discusses the morphological changes in hepatic tissue
and serum enzyme levels, resulting from a low, medium or high dose of
the inducers.
In analyzing the results of this study, it is important to consider the complexities involved in the mechanisms that produce the observed effects.

First, there are many forms of cytochrome P-450 in-

volved in the hepatic monooxygenase system.

Nebert (1979) states there

may be hundreds of inducible forms of P-450 in mammalian tissues and
these different enzyme forms may have high specificity for one inducing
substrate with some degree of cross-specificity for various other substrates.

Secondly, the inductive response in enzyme systems is not well

documented but hypothetical schemes by Conney (1967), Nebert (1979), and
Rees (1979) all refer to a receptor system which in turn regulates gene
functions controlling protein synethesis.

As a result, genetic varia-

tions between species can effect enzymatic responses produced by xenobiotics (Nebert et al. 1977).
Effects of Inducers PB, BNF and PCB on
Hepatic Monooxygenase Activity
Table 2 presents the enzyme activity of aniline hydroxylase (AH),
t-nitroanisole-Q_-demethylase (PNA) and cytochrome C reductase (CCR)
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after pretreatment of various doses of either PB, BNF, or PCB.

The en-

zyme activity within some of the pretreatment groups have a high standard deviation.

This can be explained by the strain of animals used.

Most studies utilize inbred strains of laboratory animals
the genetic variability.

to reduce

The strain of voles used in this study are

continually outbred to retain the "wild" genetic parameters, allowing
for an increase in genetic variability.

Nebert et al. (1977) explains

that monooxygenase activity fluctuates due to genetic predisposition of
each individual.

This indicates outbred voles may then have a high var-

iability in their genetic regulation of enzymatic induction.
The results shown in Figures 4-9 clearly illustrate that PB, BNF,
and PCB have varying effects on hepatic monooxygenases.

Examining the

effects produced by the high dose of the inducers, allows comparisons
to other studies.
implies

Keep in mind that 80 mg/kg pretreatment in this study

daily injections of 80 mg/kg for three days making the total

dose 240 mg/kg over a three day period.

Pretreatment with 80 mg/kg PB

had a significant inductive action on all three enzyme activities.

The

percent induction was 282%, 174%, and 73 % for AH, PNA and CCR respectively, with PNA and CCR having higher activities at 100 mg/kg PB (Table
6 and Figures 7-9).
cant

BNF pretreatment of 80 mg/kg produced a signifi-

increase only in PNA and CCR activity (Tables 4 and 5), but not

as high as PB (Figures 5 and 6).

PCB at the high dose of 80 mg/kg pro-

duced no significant increase in any of the three enzyme activities investigated.

These results are somewhat different than those reported

for other animal species.
The induction potential of polyaromatic hydrocarbon compounds (ie.
BNF and 3-MC)

on vole hepatic mixed function oxidases are dif-
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ferent than the rat, mouse or rabbi 4 but similar to the guinea pig as
illustrated by Miranda and Chhabra (1980).

They showed PB to induce the

activities of ethylmorphine demethylase, AH, 7-ethoxycoumarin deethylase
and AHH in the rat, mouse, guinea pig and rabbit; which is similar to
the results of voles.

3-MC enhanced the deethylase, AH, and AHH

activities in mice and rats, but only the AH and AHH activities in
guinea pigs.
in rabbits.

All enzyme activities were inhibited by 3-MC pretreatment
Comparison can be made between BNF induction studies and

3-MC because the effects are similar

with 3-MC having a slightly great-

er potentiation of MFO system (Boobis et al., 7977; Wang, 7987 ).
Other studies have shown species differences in vole MFO activity.
Hartgrove et al. (1977) showed a marked species difference in microsomal
MFO activity between pine voles and white mice, pretreating with endrin.
Makary and Brindley (1983) showed similar results in the mountain vole
using the substrate bi phenyl.
3-MC or BNF pretreated groups.

PB induction in voles was higher than
Also, the ratio of hydroxylated meta-

bolites (2, 3 or 4 hydroxybiphenyl) were different in voles compared to
mice.
Aroclor 1254 is a commercial mixture of PCB congeners and induces
a mixed pattern of microsomal MFO activity in mice and rats, resembling
the combined effect of 3-MC and PB (Poland and Glover, 7977; Ryan et
al .,1977).

Alvares and Kappas (1977) showed Aroclor 1254 to produce

similar induction as PB for aniline hydroxylase in rats.

Madhukar and

Matsumura (1981) investigated the effects of several inducers including
PB, 3-MC and PCB on rat hepatic MFO activity.

The activity of cyto-

chrome C reductase was highest with PB pretreatment with slight induction using 3-MC and PCB; but PNA activity showed the highest induction
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due to PCB pretreatment.

The effect of Aroclor 1254 at 80 mg/kg (simi-

lar doses were used in the studies above), on vole hepatic monooxygenase
system was minimal (Figures 3-5).

This indicated the induction system

for PCB may not be present in the mountain voles.
The most interesting aspect of the results shown in Table 2, is the
effect of different pretreatment levels of the inducers on the microsomal enzyme activity.

PB, at various levels of pretreatment, produced

a biphasic response in aniline hydroxylase (AH) as shown in Figures 3
and 6.

Pretreatment with 20 and 40 mg PB produced a significant in-

crease in AH activity over controls but therewas no difference between
the two dose levels.

The next dose level of 80 mg PBwas significantly

higher than the lower pretreatments (Table 3).

The biphasic response of

PB, may be a result of inducing two different forms of aniline hydroxylase.

McCoy (1980) identified two forms of aniline hydro xylase in ham-

sters as having
Km; form II).

high affinity (low Km; form I) and low affinity (high
McCoy (1980) determined PB pretreatment of four ip in-

jections of 80 mg/kg induced both forms of AH.

He also recalculated

data from another study, showing similar results in mice and rats.

In

voles, PB doses of 20 and 50 mg/kg may induce only one form of the microsomal AH, showing a lower induction than 80 mg/kg PB which would induce both forms of AH, producing the maximal AH activity.
PB produced a significant increase in PNA activity over controls
at 20 mg/kg and each higher dose of PB produced a significantly greater
increase in activity over the lower doses (Figure 4 and Table 4).
Boobis et al. (1977) showed

a

similar response in AHH activity with

increasing the dose of BNF and 3-MC.

Haugen (1981) also showed this

effect on biphenyl metabolism with increased levels of 3-MC and PB
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pretreatment.
Cytochrome C reductase (CCR) activity showed a triphasic response,
due to varying the dose of PB (Figure 5 and 8).
in CCR occurred at 20 mg/kg PB and 100 mg/kg
80 mg/kg (Table 5).

A significant increase

with a decrease at 50 and

This triphasic response is also seen in CCR with

pretreatment of BNF as shown in Figure 5.

Pretreatment with 5, 20 and

80 mg/kg BNF produced a significant increase in CCR activity over the
control, with 20 mg/kg BNF producing the highest response (Table 5 and
Figures 5 and 8).

The mechanism causing the triphasic responses in

CCR for PB and BNF may be similar to the effect of PB on AH;

indicat-

ing there are different forms of CCR that are affected differently depending on the dose of PB or BNF.

Another explanation may involve the

mechanism of induction as described by Bresnick (1978) and Nebert
(1979).

The cytosolic receptor that initiates the enzyme induction

process may occur in different forms.

These receptors may have vary-

ing affinities for the inducer, causing a variation in enzyme induction
depending on the dose of inducer.
This response of different receptor affinities is associated with
the effects of hormones on cell function.

In some hormonal responses,

low levels of the hormone will bind to "very high affinity" receptors
causing activation.

Increasing the hormone level causes inhibition ef-

fects due to "high affinity" receptors, whereas the highest hormone
levels would again cause activation resulting from the "low affinity"
receptors (Ellis, 1983).

This creates a triphasic

response of cellu-

lar function similar to the effect seen in CCR activity from PB and
BNF pretreatment.
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Pretreatment with BNF produced a significant decrease in PNA at
5 mg/kg with 20, 40 and 50 mg/kg showing no significant change from
control (Figure 4 and Table 4).

BNF at 80 mg/kg produced a significant

induction of PNA over the control values.

This againwas similar to

hormonal effects on cellular enzymatic activity.

Ellis and McMullen
(1982) showed B-endorphin, at a concentration of 10 -5 M, produced an

increase in monoamine oxidase activity in rat pancreas

cells.

At a

lower concentration of l □- 8 M, the monoamine oxidase activity was inhibited.
Effects of increased dose of BNF

showed a steady increase in AH,

but the activity was not significantly different from controls (Figure
3 and Table 3).

Various dose levels of PCB had no significant effect

on AH activity.

This indicated, in the vole, the dose levels given of

BNF and PCB seem to have no significant induction of the hepatic monooxygenase associated with aniline hydroxylase.

Villeneuve et al.

(1971) showed 1.0 and 10 mg/kg Aroclor 1254 had no effect on AH activity in pregnant rabbit when calculated as activity per mg protein; indicating a similarity between the vole and rabbit.
PCB pretreatment of 10 mg/kg significantly increased PNA activity
with 20 and 80 mg/kg producing no change from control and 40 mg/kg depressing PNA activity (Figure 4 and Table 4).

Cytochrome C reductase

activity showed a significant increase at 5 mg/kg PCB with no effect at
the higher doses.

As mentioned earlier, PCB produces an induction

similar to the combined effect of PB and 3-MC in rats and mice.

The

results obtained from voles must be species specific by showing no induction or even a reduction of MFO activity at higher dose levels of
PCB.
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Effects of PB, BNF and PCB on Serum Enzyme
Levels and Hepatic Morphology
Altered membrane permeability of hepatic cells can lead to increased
serum enzyme activity (Plaa, 1980).

Serum glutamic-pyruvic transaminase

(SGPT) is released from the cytoplasm of injured liver cells and appears
to be a more sensitive index of hepatic injury than other serum assays
(Balazs et al., 1962; Traiger and Plaa, 1971; Thomson, 1978).

Talcott

and Ketterman (1981) indicated that serum levels of malathion carboxylesterase may vary due to changes in liver endoplasmic reticulum.

They

showed a high correlation between SG0T levels and serum malathion carboxylesterase titers.

This suggested that serum activity of malathion

carboxylesterase may increase when liver damage occurs.
Changes in SGPT units and serum malathion carboxylesterase activity due to PB, BNF or PCB pretreatment, are shown in Table 7.

The three

inducers, at different doses, caused a decrease in SGPT units compared
to control values (Table 7).

Carbon tetrachloride was used for a posi-

tive control, elevating the SGPT units to a mean value of 1475 compared
to 60 from the oil-control animals.

Normal levels of SGPT units in hu-

mans range from 6 to 36 (Todd- Sanford, 1974),
0 as being normal.

showing a level close to

This indicates the decrease in SGPT units observed

in the inducer pretreated animals, really is not a positive indicator of
any liver changes.

The lower values in the treatment groups illustrate

the variability that occurs in normal vole SGPT levels; with the upper
limit being approximately 117 and a lower value near 5.

Pessayre et al.

(1980) showed PB and 3-MC had no effect on the SGPT levels in rats,
agreeing with the vole results shown in Table 7.
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The effect of PB, BNF or PCB on serum malathion carboxylesterase
activity is shown in Table 7 with similar results as indicated by SGPT.
Carbon tetrachloride, again

used as a positive control, produced a

significant increase in serum malathion carboxylesterase activity compared to the controls and other treatment groups.

Two samples of rat

serum were assayed, to determine how well the assay was running.

The

mean value, 23.9 n mole/mg Protein-min, matched the value obtained by
Talcott (1979), indicating the assay was working correctly.

The results

of the rats also : ~owed a significant increase in activity compared to
vo 1es.
General effects of inducer pretreatment on vole body weight and
1 ivers are shown in Table 1.
liver weights occurred

No significant changes in body weight or

between the pretreatment groups.

significant increase in liver

There was a

weight in relation to body weight with

50, 80, and 100 mg/kg PB and 80 mg/kg PCB compared to the control values
(Table 1).

Also, 50, 80, and 100 mg/kg PB caused a significant increase

in microsomal protein per gr.am liver weight.
(1975) found

Augenlicht and Argyris

pretreatment with PB or 3-MC resulted in increased liver

growth in rats.

Argyris (1968) showed rats pretreated with 100 mg/kg

PB for 5 days produced an increase in liver weight and total protein
which was associated with the increase of aminopyrine demethylase activity.

This is in agreement with the results obtained on the voles

shown in Table 1.

Argyris and Layman (1969) showed a slight increase

in total liver weight and protein in 3-MC treated immature rats.
Conney and Gilman (1963) illustrated only PB and not 3-MC produced an
increase in microsomal protein per g of liver for mature rats.
These studies by Argyris and co-workers, indicate monoo xygenase
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induction is closely associated with increased liver weights and microsomal protein content.

This association was demonstrated in the vole

work with the increase induction of monooxygenase enzyme activity shown
in Table 2 with PB treatment and the effects on liver weight and protein in Table 1.

Pretreatment with BNF or PCB produced little change

or a decrease in microsomal protein and the same effect was demonstrated
in the enzyme activity.

This again supports the rational that BNF and

PCB have little inductive effects in the vole on the enzymes studied.
Both vehicle treatments, saline and oil, produced a significant
decrease in microsomal protein per gram liver weight.

This may be due to

the increase in saline or oil uptake into hepatocytes causing a slight
increase in liver weight compared to protein content.

The effect may

not be seen when a compound is present in the saline or oil because
slight increases in protein content may occur in response of the metabolism of the compound, thus nullifying the change in liver weight.
Gross pathological examination of livers from PB treated voles,
showed enlarged livers which correlated well with the results in Table
1 on liver weights and protein content.

Both BNF and PCB were adminis-

tered in oil causing greasy livers and at higher dose levels, fibrin
tabs were present.
Histological evaluation revealed similar changes between PB, BNF,
and PCB treatment groups, but the effect varied between the inducers
depending on the dose.

At the lower dose levels, all three inducers

produced foamy and vacuolated hepatocytes.

This effect was primarily

centrilobular in 5 mg / kg PB treated animals while 5 mg BNF pretreatment
caused centrilobular and midzonal vacuolated cells (Figure 13).

PCB

at 5 mg/kg also showed severe vacuolization of centrilobular and mid-
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zonal hepatocytes as shown in Figure 15.

This variation of localized

inducer effects within the liver lobule, agrees with the current literature showing regional organization of different monooxygenase enzymes
within the liver lobule (James et al., 1981; W
.ilson and Hart, 1981 ).
Baron et al. (1978) used immunohistochemicaltechniques to sho\<1 PB induced cytochrome P-450 to be located primarily in the centrilobular
regions while 3-MC indu ced cytochromes were located more uniformil y
throug hout the lobule.

Gumbrecht and Franklin (1982) showed the pres-

ence of different cytochrome P-450 subpopulations distributed within the
liver lobule, with PB preferentially inducing the P-450 species found
primarily in the centrilobular region.
High er dose levels of PB (80 mg/kg) showed decreased vacuolization
with hepatocytes becoming extremely hypertrophied throughout the lobule
(Figure 12).

The high doses of BNF and PCB produced livers with some

vacuolization still present but some tissues showed hypertrophied cells
(Figures 14 and 16), but not as severe as 80 mg/kg PB.

Wanson et al.

(1975) showed enlarged hepatocytes with an intense proliferation of
smooth endoplasmic reticulum (SER) in rats pretreated with PB.

Centro-

lobular hepatocytes were affected initially, but with a longer pretreatment schedule the entire lobule became

involved.

Orrenius et al.

(1965) and Staubli et al. (1969) performed similar ultrastructural
studies in rats, also showing the proliferation of smooth ER in PB
treated animals.
Fouts and Rogers ( 1965) investigated the effects of PB and 3-MC on
hepatocyte ultrastructure in rats.

PB again

produced proliferation in

smooth ER along with increased enzymatic activity of several substrates.
Pretreatment with 3-MC produced a slight increase in smooth ER and in-
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duction of only one enzymatic activity.

Results from Fouts and Rogers

agreed with the conclusions of Conney and Gilman (1963)

that 3-MC, in

contrast to PB, only induces a selective number of hepatic microsomal
enzymes producing minimal changes in smooth ER and microsomal protein.
The conclusions of Fouts and Rogers (1965) help to explain the results produced by vole induction of PB, BNF and PCB.

Primary inductive

changes involves vacuolization of hepatocytes and reveals small induction of hepatic microsomal enzymes.
three inducers.

This occurs at low doses of all

High levels of PB pretreatment produces a secondary

morphological response of large, hypertrophied hepatocytes as seen in
Figure 12.

Along with this change, is a large induction of all three

hepatic microsomal enzymes.

Pretreatment with 80 mg/kg BNF or PCB

doesn't produce the secondary changes seen with PB.

This implies that

BNF and PCB inductive response is either minimal in the mountain vole
or that the response is very selective, affecting the activity of a select group of enzymes, different than the ones tested in this study.

Ad-

ditional studies investigating the vole hepatocyte ultrastructure and
testing with a wider range of microsomal enzyme assays, may help to
understand the phenomenon occurring at higher inducer pretreatment levels in the mountain vole.
The effect of carbon tetrachloride on vole hepatic tissue was investigated to give a positive control on hepatic necrosis.
are shown in Figures 17 and 18.

The results

The acute effects of carbon tetrachlor-

ide on vole hepatic tissue resembles the classical centrilobular and
midzonal acute necrosis with periportal fatty degeneration, demonstrated
in other species (Pl aa, 1980 ; J ames et al . , 1981 ) .

The initial necrosis

occurred in the centrilobular and periportal regions because of the concen-
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tration of enzymes that metabolize the chlorinated hydrocarbon into the
toxic free radical.
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CONCLUSION
The hepatic monooxygenase system plays an important role in both
the detoxification as well as the activation of many xenobiotics.
There are many forms of cytochrome P-450 involved in the hepatic monooxygenase system, allowing for a high degree of versitility in substrates the system can metabolize.
tics of this system

One of the interesting characteris-

is the ability of certain compounds to induce the

rate of enzymatic activity.

It is important in toxicology to understand

the interactions and effects of drugs and environmental contanimants on
the metabolic activity of liver monooxygenases.
Previous work has shown the mountain vole, Microtus montanus, to
have different induction capabilities compared to the rat or mouse.
This indicated a need to further investigate the inductive properties
of the hepatic monooxygenase system in the vole.
In this study, the effects of three inducers phenobarbital (PB),
B-naphthoflavone (BNF), and Aroclor 1254 (PCB), at high doses, showed
differing responses on vole hepatic microsomal monooxygenases.

PB at

80 mg/kg produced a significant increase in activity of all three enzymes tested whereas 80 mg/kg BNF and PCB did not.

BNF produced little

change in aniline hydroxylase (AH) activity and a slight induction of
~-nitroanisole-0-demethylase (PNA) and cytochrome C reductase (CCR).
Pretreatment with PCB produced no change in AH, PNA or CCR activity.
The effects of BNF and PCB on the hepatic monooxygenase activity, was
in contrast with reports on other species.
Varying the pretreatment dose produced interesting results on the
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hepatic enzyme activity.

PB showed a biphasic response in AH activity

with 20 mg/kg dose increasing activity over control values, 50 mg/kg
produced the same effect as 20 mg, and 80 mg/kg showed an increase over
the 20, and 50 mg dose.

This is attributed to, two different affinity

types of aniline hydroxylase having different inductive capabilities.
The effect of PB on PNA showed each increase in PB dose produced a higher
induction of the enzyme activity.

With CCR, the activity increased at

20 mg/kg, decreased back to control values at 50 mg/kg and increased
again at 80 and 100 mg/kg

resulting in a triphasic response.

Different levels of BNF pretreatment showed no significant increases over control values in AH activity.

The dose of 5 mg/kg BNF re-

duced the activity of PNA, with 20, 40 and 50 mg/kg having no chang~
from controls.

The level of 80 mg/kg BNF produced a significant in-

crease in PNA activity.

The effect of varying the dose of BNF, on PNA

activity showed a biphasic response.

A triphasic response was shown

for the effect of BNF on CCR with 20 mg/kg BNF producing a large induction, decreasing to normal activity at 40 and 50 mg/kg and again increasing significantly over control at 80 mg/kg.
The effects of various doses of PCB on AH activity was no different than controls.

With PNA, the activity increase at the low dose of

10 mg/kg and reduction occurred at 40 mg/kg.
control values at the other dose levels.

There was no change from

The effects of PCB at 5 mg/kg

increased CCR activity but no differences from control values were
shovm at higher levels of PCB.
The results of BNF and PCB would indicate that adverse changes
may be occurring in the hepatocytes.

But the levels of SGPT and serum

malathion carboxylesterase, which at high levels are indicative of liver
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damage, remained the same as control levels in all the inducer pretreatment doses.

Upon histogical examination, the cellular features were

similar between the PB, BNF and PCB pretreatment groups, indicating no
necrosis from any of the inducers.

There were two major morphological

phases that occurred in the hepatocytes.

The first phase involved

vacuolated hepatocytes and was associated with the low dose inducer
pretreatment groups.

These groups either had no induction of the en-

zymes tested or slight increase in activity.
enlarged, swollen, hypertrophied hepatocytes.

The second phase showed
This was typical of the

higher doses of PB but only present in some tissues from the high doses
of BNF and PCB.

This indicates that the second phase is associated with

the higher inductive response of monooxygenase activity.
The results of different enzyme activities, due to various doses
of inducers, indicates the complexities involved in the induction mechanism of hepatic monooxygenases.

The biphasic and triphasic responses,

resembles the effects of different hormone levels, on cellular function
involving different affinity receptors in the hormonal response.

This

same system of different receptors may be involved in the process of induction in the monooxygenase system.

Further

studies are needed to

better understand this mechantsm; in the mean time, to xicological
studies should be aware of possible induction differences, based on the
pretreatment dose.
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